Thus, it can be assumed that PD-L1 upregulation induced by RT gives rise to an immunosuppressive tumor microenvironment, which, on the one hand, impairs the efficacy of RT but supports the use of ICIs in RT to overcome resistance. This evidence concerns the gene CD274 and neoplasm.